Genetracer Biotech has participated for the second consecutive year as EQA Assessor Scheme for Lung cancer

Between 12 and 15 October and based on experience gained in the field of oncology, Genetracer Biotech has participated as EQA (External Quality Assessment) Assessor Scheme for lung cancer.

The objective is annual provision of EQA schemes which meet international quality standards. The overall aim is improvement in the quality of molecular (genetic) testing.


EMQN web


October th19, 2016|Categories: About GTB @en|0 Comments

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.